Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Communications symbols : Sny save search
PRODUCT OF THE YEAR USA NAMES 2024 AWARD WINNERS
Published: 2024-02-09 (Crawled : 14:00) - prnewswire.com
K | $56.07 1.01% 0.0% 1.8M
|
Consumer Non-Durables
|
| O: -0.38%
H: 0.03%
C: -2.27%
EPC 4 | $35.32 -0.4% 0.0% 250K
|
Consumer Non-Durables
|
| O: -0.35%
H: 0.61%
C: 0.31%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 1.11%
H: 0.0%
C: 0.0%
award year usa
Publicis Groupe : Full Year 2023 Results
Published: 2024-02-08 (Crawled : 07:00) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -2.28%
H: 0.0%
C: 0.0%
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -1.64%
H: 0.0%
C: 0.0%
K | $56.07 1.01% 0.0% 1.8M
|
Consumer Non-Durables
|
| O: 3.37%
H: 1.93%
C: -1.01%
KBH S | $60.92 -1.47% 0.0% 890K
|
Consumer Durables
|
| O: 0.25%
H: 1.03%
C: 0.9%
GM | News | $42.46 -0.47% 0.02% 11M
|
Consumer Durables
|
| O: 0.31%
H: 0.26%
C: -0.49%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -2.25%
H: 0.0%
C: 0.0%
year results
Sanofi Digital Transformation Strategy Analysis Report 2023: Accelerators, Incubators, and Other Innovation Programs
Published: 2024-01-11 (Crawled : 02:00) - prnewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: 1.1%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
report innovation sanofi
Incretin-based Drugs Market to Reach $73.9 billion, globally, by 2032 at 7.9% CAGR: Allied Market Research
Published: 2023-12-15 (Crawled : 15:30) - prnewswire.com
AZNCF | $135.305 -4.19% 1.1K
|
Health Technology
|
| O: -3.0%
H: 2.15%
C: 2.15%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: -0.44%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: -1.31%
H: 0.56%
C: -0.17%
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: -4.44%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
AZN | $68.53 0.39% 0.39% 3.7M
|
Health Technology
|
| O: -2.23%
H: 0.28%
C: -0.11%
reach research market
Sodexo announces the composition of Pluxee’s future Board of Directors
Published: 2023-12-13 (Crawled : 07:00) - globenewswire.com
LDNXF | $112.038 -12.32% 1K
|
Finance
|
| O: 2.99%
H: 0.0%
C: -2.02%
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -0.06%
H: 2.36%
C: 2.36%
BGAOY | News | $1.5 38.89% 1.1K
|
Information
|
| O: 1.56%
H: 0.0%
C: 0.0%
LNSTY | $28.87 0.53% 82K
|
Finance and Insurance
|
| O: -0.61%
H: 2.21%
C: 1.81%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.27%
H: 2.28%
C: 2.16%
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
TEVA | $13.18 0.69% 0.46% 6.6M
|
Health Technology
|
| O: -0.52%
H: 3.73%
C: 1.87%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -1.09%
H: 0.0%
C: 0.0%
disease treatment collaboration teva deal
Rabies Vaccine Market to Reach $ 1903.17 million by 2032, exhibiting a CAGR of 4.7% from 2023 to 2032: Allied Market Research
Published: 2023-11-25 (Crawled : 08:20) - prnewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
| Email alert
Add to watchlist
ELAN | $13.41 -1.69% -0.45% 4.1M
|
Process Industries
| Email alert
Add to watchlist
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
ZTS | News | $151.94 -0.71% 2.38% 3.3M
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
vaccine reach research market
Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
Published: 2023-11-08 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
TEVA | $13.18 0.69% 0.46% 6.6M
|
Health Technology
|
| O: 2.54%
H: 3.23%
C: -1.29%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
revenue teva financial results
Oral Antibiotics Market to Reach $28.8 Billion, Globally, by 2032 at 2.5% CAGR: Allied Market Research
Published: 2023-10-25 (Crawled : 14:00) - prnewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: 0.4%
H: 1.29%
C: 1.29%
VTRS | $11.095 -0.22% -0.23% 6.1M
|
Health Technology
|
| O: -0.44%
H: 0.33%
C: -1.1%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: 0.64%
H: 0.46%
C: -0.09%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 1.43%
H: 0.64%
C: -0.09%
reach antibiotics research market
Pharmaceutical Suppositories Market to Reach $2.8 Billion, Globally, by 2032 at 5.7% CAGR: Allied Market Research
Published: 2023-10-24 (Crawled : 01:00) - prnewswire.com
VTRS | $11.095 -0.22% -0.23% 6.1M
|
Health Technology
|
| O: 0.45%
H: 2.46%
C: 1.67%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: -0.17%
H: 1.02%
C: 0.4%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.77%
H: 0.0%
C: 0.0%
reach research market
Antibody Drug Conjugate - Competitive Landscape 2023 Study: Featuring Coverage on 180+ Companies and 300+ Drugs
Published: 2023-06-30 (Crawled : 18:00) - prnewswire.com
SRNE | $0.0275 -8.85% 53K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
| Email alert
Add to watchlist
IMGN | $31.23 0.03% 49M
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
drug companies antibody
Antibody-drug Conjugates Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain
Published: 2023-06-26 (Crawled : 21:00) - prnewswire.com
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 2.15%
H: 1.18%
C: 0.43%
SRNE | $0.0275 -8.85% 53K
|
Health Technology
|
| O: -1.0%
H: 4.2%
C: 1.3%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.82%
H: 0.02%
C: -0.85%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.17%
H: 0.0%
C: 0.0%
OMER | $3.32 -3.21% -3.31% 270K
|
Health Technology
|
| O: 0.19%
H: 2.22%
C: 1.76%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 0.58%
H: 2.57%
C: 0.26%
companies pipeline trial
Extended Release Injectable Drugs Research Report 2023: Formulation Technologies & Platforms, Physical Process Control Methods, Development Factors, Competitive Landscape
Published: 2023-06-16 (Crawled : 23:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
| Email alert
Add to watchlist
report control research
IPG Named Most Effective Holding Company at the U.S. Effie Awards
Published: 2023-06-02 (Crawled : 22:00) - interpublic.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
| Email alert
Add to watchlist
awards
IPG Receives Back-to-Back Title as Most Effective Holding Company at the Effie Awards
Published: 2023-06-02 (Crawled : 20:00) - interpublic.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
| Email alert
Add to watchlist
awards
Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference
Published: 2023-01-24 (Crawled : 11:00) - nutriband.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -0.27%
H: 0.1%
C: 0.1%
NTRB | $4.01 2.74% 8.9K
|
Manufacturing
|
| O: -2.85%
H: 0.0%
C: -1.76%
RANI | $7.77 13.1% 11.58% 1.4M
|
|
| O: -1.1%
H: 1.91%
C: -3.82%
MRK | $125.37 0.25% 0.1% 6.1M
|
Health Technology
|
| O: 0.11%
H: 0.0%
C: -1.35%
GSK | $39.6 -0.88% 0.0% 2.8M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: -0.86%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.72%
H: 0.0%
C: 0.0%
conference transdermal
Pfizer and BioNTech Receive U.S. FDA Fast Track Designation for Single-Dose mRNA-Based Vaccine Candidate Against COVID-19 and Influenza
Published: 2022-12-09 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
PFE A | $25.42 -1.05% -0.04% 44M
|
Health Technology
|
| O: -0.06%
H: 2.11%
C: -0.06%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -0.05%
H: 0.75%
C: -0.83%
covid-19 fda designation candidate vaccine influenza fast track designation
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
Published: 2022-12-08 (Crawled : 16:00) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -0.76%
H: 0.0%
C: 0.0%
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
PFE A | $25.42 -1.05% -0.04% 44M
|
Health Technology
|
| O: -0.12%
H: 3.36%
C: 3.19%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 0.37%
H: 5.31%
C: 5.26%
covid-19 fda children vaccine authorization
Pfizer and BioNTech Report New Data on Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Improved Immune Response Against Emerging Omicron Sublineages
Published: 2022-11-18 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: 1.56%
H: 0.52%
C: 0.52%
PFE A | $25.42 -1.05% -0.04% 44M
|
Health Technology
|
| O: 0.64%
H: 0.39%
C: -0.84%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 2.2%
H: 0.0%
C: 0.0%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -0.29%
H: 0.78%
C: 0.37%
report response
Pfizer and BioNTech Advance Next-Generation COVID-19 Vaccine Strategy with Study Start of Candidate Aimed at Enhancing Breadth of T cell Responses and Duration of Protection
Published: 2022-11-16 (Crawled : 00:00) - globenewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -1.22%
H: 0.0%
C: 0.0%
PFE A | $25.42 -1.05% -0.04% 44M
|
Health Technology
|
| O: -0.52%
H: 1.45%
C: 1.11%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -2.28%
H: 0.0%
C: 0.0%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -1.45%
H: 2.36%
C: 2.31%
covid-19 candidate vaccine study
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.